logo
logo

Presidio Medical Announces $30 Million Financing Round Led by Invus Opportunities

Jul 14, 2020•about 5 years ago

Amount Raised

$30 Million

San Francisco

Description

Presidio Medical, Inc., a clinical-stage medical device company developing a neuromodulation platform technology with an initial indication to treat chronic pain, today announced it has closed $30 million in financing. The financing round was led by Invus Opportunities, with participation from existing investor, Action Potential Venture Capital.

Company Information

Company

Presidio Medical

Location

San Francisco, California, United States

About

We are a clinical-stage, privately held medical technology company developing a transformational neuromodulation platform to treat diseases of undesired neural activity.

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Related People